Tumapon, Euryn-joy L.
HRN: 15-03-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 750MG (VIAL)
04/30/2022
05/06/2022
IV
500mg
Q8H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes